Valuation: Cencora, Inc.

Market Cap 62.09B 55.71B 51.5B 46.64B 87.14B 5,913B 88.2B 616B 245B 3,094B 233B 228B 9,824B P/E 2026 *
17.8x
P/E 2027 * 19.7x
Enterprise Value 69.53B 62.38B 57.67B 52.23B 97.58B 6,622B 98.76B 690B 275B 3,465B 261B 255B 11,000B EV / Sales 2026 *
0.21x
EV / Sales 2027 * 0.19x
Free-Float
61.21%
Yield 2026 *
0.73%
Yield 2027 * 0.75%
1 day-0.31%
1 week-4.72%
Current month+8.03%
1 month+6.76%
3 months+1.49%
6 months+3.96%
Current year-3.97%
1 week 320.06
Extreme 320.06
344.43
1 month 295.01
Extreme 295.01
345.46
Current year 244.82
Extreme 244.82
376.92
1 year 244.82
Extreme 244.82
377.54
3 years 182.75
Extreme 182.75
377.54
5 years 113.68
Extreme 113.68
377.54
10 years 68.7
Extreme 68.705
377.54
Manager TitleAgeSince
Chief Executive Officer 59 2024-09-30
Director of Finance/CFO 59 2026-06-28
Chief Tech/Sci/R&D Officer 50 2024-11-03
Director TitleAgeSince
Director/Board Member 75 2013-05-15
Director/Board Member 59 2024-09-30
Chairman 64 2025-09-30
Date Insider Type Main position Quantity % Market Cap. Importance
10/1/26 Other

Director

275 0.0001%
10/1/26 Sell

Controller/Auditor

-986 0.0005%
10/1/26 Other

Director

197 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-0.31%-4.72%-3.36%+74.94% 62.09B
-0.45%+2.17%-18.89%+10.42% 178B
+0.86%+2.21%-19.09%+15.84% 116B
+0.88%+1.88%+1.66%+35.46% 115B
-2.26%+18.07%-43.85%+5.76% 93.1B
+0.17%+1.64%+8.50%+82.24% 55.87B
+0.07%+0.42%+5.94%-22.27% 53.12B
+0.30%+1.70%-11.26%+42.01% 44.22B
+0.10%+3.08%-3.06%-8.74% 33.59B
+0.08%-2.04%+13.56%-7.41% 29.65B
Average +0.03%+1.97%-6.99%+22.82% 78.07B
Weighted average by Cap. +0.11%+3.19%-11.64%+22.69%

Financials

2026 *2027 *
Net sales 337B 302B 280B 253B 473B 32,099B 479B 3,343B 1,331B 16,797B 1,265B 1,238B 53,324B 352B 316B 292B 264B 494B 33,494B 500B 3,488B 1,389B 17,527B 1,320B 1,292B 55,642B
Net income 3.58B 3.21B 2.97B 2.69B 5.02B 341B 5.09B 35.51B 14.14B 178B 13.44B 13.15B 566B 2.84B 2.55B 2.36B 2.14B 3.99B 271B 4.04B 28.22B 11.24B 142B 10.68B 10.45B 450B
Net Debt 7.44B 6.67B 6.17B 5.59B 10.44B 708B 10.56B 73.76B 29.38B 371B 27.91B 27.32B 1,177B 5.95B 5.33B 4.93B 4.47B 8.35B 566B 8.45B 58.97B 23.49B 296B 22.31B 21.84B 941B
Projected Income Statement - Annual - Cencora, Inc.
Logo Cencora, Inc.
Cencora, Inc. specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services, prescription management services, nursing services, home injection and perfusion services, etc.).
Employees
49,000
Date Price Change Volume
26-10-28 $324.35 -0.31% 1,076,734
26-10-27 $325.37 -1.40% 1,123,060
26-10-26 $330.00 -0.30% 993,480
26-10-23 $331.00 -2.21% 1,168,293
26-10-22 $338.48 -0.57% 1,183,276
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Cencora, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
325.37USD
Average target price
369.08USD
Spread / Average Target
+13.43%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Cencora, Inc.